CAITLIN TUMMINELLI: Open Payments
NPI 1417315862 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 47 payments from 10 companies in 2025. Trend: 2023 $457 · 2024 $885 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $204 |
| Edwards Lifesciences Corporation | 1 | $181 |
| AstraZeneca Pharmaceuticals LP | 4 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $85 |
| Novo Nordisk Inc | 4 | $73 |
| CVRx, Inc. | 3 | $46 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| PFIZER INC. | 1 | $19 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, SAPIEN 3 Ultra RESILIA, LOKELMA, JARDIANCE, Wegovy, FARXIGA, Barostim Neo System, LifeVest.
Industry payments across NJ — which companies pay providers there.
